Alnylam Pharmaceuticals and Medtronic, Inc.'s Joint Project to Block Gene in Huntington’s

Wall Street Journal -- A medical breakthrough that was awarded a Nobel Prize in 2006 is now being tapped in an effort to develop a possible treatment for Huntington's disease, the genetic disorder that killed legendary singer and songwriter Woody Guthrie.
MORE ON THIS TOPIC